RS20060023A - Use of soluble cd164 in inflammatory and/or autoimmune disorders - Google Patents

Use of soluble cd164 in inflammatory and/or autoimmune disorders

Info

Publication number
RS20060023A
RS20060023A YUP-2006/0023A YUP20060023A RS20060023A RS 20060023 A RS20060023 A RS 20060023A YU P20060023 A YUP20060023 A YU P20060023A RS 20060023 A RS20060023 A RS 20060023A
Authority
RS
Serbia
Prior art keywords
autoimmune disorders
inflammatory
soluble
human
relates
Prior art date
Application number
YUP-2006/0023A
Other languages
English (en)
Inventor
Yolande Chvatchko
Original Assignee
Applied Research Systems Ars Holding N.V.,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems Ars Holding N.V., filed Critical Applied Research Systems Ars Holding N.V.,
Publication of RS20060023A publication Critical patent/RS20060023A/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Abstract

Ovaj pronalazak se odnosi na nove terapijske upotrebe solubilnih proteina koji obuhvataju ekstracelularni region humanog CD164, posebno za terapiju inflamatornih i/ili autoimunih poremećaja.
YUP-2006/0023A 2003-07-23 2004-07-23 Use of soluble cd164 in inflammatory and/or autoimmune disorders RS20060023A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03077316 2003-07-23
PCT/EP2004/051596 WO2005011728A2 (en) 2003-07-23 2004-07-23 Use of soluble cd164 in inflammatory and/or autoimmune disorders

Publications (1)

Publication Number Publication Date
RS20060023A true RS20060023A (en) 2008-06-05

Family

ID=34112463

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-2006/0023A RS20060023A (en) 2003-07-23 2004-07-23 Use of soluble cd164 in inflammatory and/or autoimmune disorders

Country Status (15)

Country Link
US (2) US20060257402A1 (sr)
EP (1) EP1646396A2 (sr)
JP (1) JP4705028B2 (sr)
KR (1) KR20060106810A (sr)
CN (1) CN1845752A (sr)
AR (1) AR045074A1 (sr)
AU (1) AU2004260835A1 (sr)
BR (1) BRPI0412243A (sr)
CA (1) CA2532870A1 (sr)
EA (1) EA009389B1 (sr)
IL (1) IL173197A0 (sr)
NO (1) NO20060781L (sr)
RS (1) RS20060023A (sr)
WO (1) WO2005011728A2 (sr)
ZA (1) ZA200600193B (sr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2595795A1 (en) 2005-01-24 2006-07-27 Laboratoires Serono S.A. Use of soluble cd164 variants in inflammatory and/or autoimmune disorders
DK2614832T3 (da) 2007-02-12 2016-10-31 A1M Pharma Ab Diagnose og behandling af præeklampsi
JP5694928B2 (ja) * 2008-07-18 2015-04-01 エー１エム ファーマ エービーＡ１Ｍ Ｐｈａｒｍａ ＡＢ ラジカルスカベンジャー及び抗酸化剤アルファ−１−ミクログロブリンの医薬的使用
US8392585B1 (en) * 2011-09-26 2013-03-05 Theranos, Inc. Methods and systems for facilitating network connectivity
WO2022099695A1 (en) * 2020-11-16 2022-05-19 Jiangsu Cell Tech Medical Research Institute Co., Ltd. Cd164 fusion and uses thereof
CN114891107A (zh) * 2022-05-12 2022-08-12 北京农学院 一种抗猪cd164l2单克隆抗体制备与应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2296792A1 (en) * 1999-02-26 2000-08-26 Genset S.A. Expressed sequence tags and encoded human proteins
US20040010119A1 (en) * 2001-02-12 2004-01-15 Xiaojia Guo Novel proteins and nucleic acids encoding same

Also Published As

Publication number Publication date
US20060257402A1 (en) 2006-11-16
CN1845752A (zh) 2006-10-11
KR20060106810A (ko) 2006-10-12
JP4705028B2 (ja) 2011-06-22
ZA200600193B (en) 2007-04-25
CA2532870A1 (en) 2005-02-10
AR045074A1 (es) 2005-10-12
US8075894B2 (en) 2011-12-13
BRPI0412243A (pt) 2006-09-19
US20090285838A1 (en) 2009-11-19
IL173197A0 (en) 2006-06-11
EA009389B1 (ru) 2007-12-28
EA200600314A1 (ru) 2006-06-30
NO20060781L (no) 2006-03-17
JP2006528159A (ja) 2006-12-14
WO2005011728A3 (en) 2005-06-02
AU2004260835A1 (en) 2005-02-10
EP1646396A2 (en) 2006-04-19
WO2005011728A2 (en) 2005-02-10

Similar Documents

Publication Publication Date Title
MXPA05010830A (es) Metodos de tratamiento que usan agentes de enlace especificos de angiopoyetina-2 humana.
YU37304A (sh) Specifični agensi koji vezuju humani angiopoetin-2
MXPA06014510A (es) Composiciones y metodos para tratar trastornos inflamatorios.
TW200732347A (en) VEGF analogs and methods of use
HK1080467A1 (en) Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders
ATE330967T1 (de) An her2 bindende peptidverbindungen
TW200612905A (en) Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
MY147767A (en) Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
HK1096392A1 (en) Substituted heterocycles
WO2003101401A3 (en) Use of nrg4, or inhibitors thereof, in the treatment of colon and pancreatic cancer
WO2004024097A8 (en) Compositions and methods for the treatment of immune related diseases
UA85559C2 (en) Aminobenzophenone compounds
CO5660287A2 (es) Derivados de tetrahidrocarbazol y su uso farmaceutico
RS89204A (en) Use of osteoprotegerin for the treatment and/or prevention of fibrotic disease
PL356846A1 (en) Use of interleukin-6 antagonists for the treatment of diseases characterised by high levels of aromatase
IL171384A (en) Use of slurp-1 in the preparation of medicaments for the treatment of neurological disorders
WO2004032850A3 (en) Uses of human zven antagonists
NO20060781L (no) Anvendelse av loselig CD164 ved inflammatoriske og/eller autoimmune lidelser
MXPA05011699A (es) Inhibidores de la bomba de protones para el tratamiento de trastornos del abdomen inferior.
DE602004019541D1 (de) Cycloalkyläbü kondensierte indole
IL174134A0 (en) Use of a protein in the preparation of a medicament for treatment of fibrotic diseases
AU2003259750A8 (en) Methods and compositions for targeting secretory lysosomes
SE0202608D0 (sv) New sequences
MY135649A (en) Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders
TW200635950A (en) Specific binding agents of human angiopoietin-2